Zurich Insurance Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $60.3M | Sell |
277,386
-102,803
| -27% | -$22.8M | 0.47% | 52 |
|
|
2025
Q4 | $86.9M | Sell |
380,189
-418,677
| -52% | -$95.4M | 0.6% | 38 |
|
|
2025
Q3 | $185M | Buy |
798,866
+149,469
| +23% | +$30.4M | 1.32% | 13 |
|
|
2025
Q2 | $121M | Buy |
649,397
+58,441
| +10% | +$10.9M | 0.93% | 31 |
|
|
2025
Q1 | $124M | Buy |
590,956
+170,629
| +41% | +$33.2M | 1% | 25 |
|
|
2024
Q4 | $74.7M | Buy |
420,327
+43,991
| +12% | +$8.09M | 0.61% | 45 |
|
|
2024
Q3 | $74.3M | Sell |
376,336
-115,774
| -24% | -$21.6M | 0.63% | 50 |
|
|
2024
Q2 | $84.4M | Sell |
492,110
-227,025
| -32% | -$37.6M | 0.73% | 39 |
|
|
2024
Q1 | $131M | Buy |
719,135
+377,299
| +110% | +$65M | 1.2% | 15 |
|
|
2023
Q4 | $53M | Sell |
341,836
-548,547
| -62% | -$80M | 0.54% | 60 |
|
|
2023
Q3 | $133M | Buy |
+890,383
| New | +$131M | 1.41% | 16 |
|
|
2023
Q2 | – | Sell |
-174,757
| Closed | -$27.9M | – | 242 |
|
|
2023
Q1 | $27.9M | Buy |
+174,757
| New | +$26.7M | 0.35% | 90 |
|
|
2020
Q1 | – | Sell |
-675,728
| Closed | -$59.8M | – | 204 |
|
|
2019
Q4 | $59.8M | Buy |
675,728
+382,388
| +130% | +$31.7M | 1.08% | 26 |
|
|
2019
Q3 | $22.2M | Buy |
293,340
+40,614
| +16% | +$2.78M | 0.42% | 56 |
|
|
2019
Q2 | $18.4M | Sell |
252,726
-42,907
| -15% | -$3.37M | 0.36% | 62 |
|
|
2019
Q1 | $23.8M | Buy |
295,633
+54,104
| +22% | +$4.43M | 0.51% | 51 |
|
|
2018
Q4 | $22.3M | Sell |
241,529
-10,677
| -4% | -$939K | 0.53% | 48 |
|
|
2018
Q3 | $23.9M | Buy |
252,206
+8,219
| +3% | +$779K | 0.51% | 46 |
|
|
2018
Q2 | $22.6M | Sell |
243,987
-62,631
| -20% | -$6.12M | 0.51% | 39 |
|
|
2018
Q1 | $29M | Sell |
306,618
-14,606
| -5% | -$1.6M | 0.67% | 28 |
|
|
2017
Q4 | $31.1M | Buy |
321,224
+115,076
| +56% | +$10.8M | 0.73% | 29 |
|
|
2017
Q3 | $18.3M | Sell |
206,148
-5,656
| -3% | -$431K | 0.5% | 43 |
|
|
2017
Q2 | $15.4M | Sell |
211,804
-14,641
| -6% | -$984K | 0.44% | 49 |
|
|
2017
Q1 | $14.8M | Sell |
226,445
-5,226
| -2% | -$329K | 0.43% | 51 |
|
|
2016
Q4 | $14.5M | Sell |
231,671
-10,539
| -4% | -$643K | 0.46% | 46 |
|
|
2016
Q3 | $15.3M | Buy |
242,210
+23,332
| +11% | +$1.51M | 0.51% | 42 |
|
|
2016
Q2 | $13.6M | Sell |
218,878
-27,020
| -11% | -$1.65M | 0.47% | 56 |
|
|
2016
Q1 | $14M | Buy |
245,898
+34,681
| +16% | +$1.93M | 0.5% | 51 |
|
|
2015
Q4 | $12.5M | Buy |
+211,217
| New | +$12.2M | 0.45% | 64 |
|
Other funds holding ABBV
VCM
VPM
Zurich Insurance Group's ABBV Position: Q1 2026 in Review
Zurich Insurance Group reduced its AbbVie (ABBV) stake by 27% in Q1 2026, selling an estimated $22.8M and leaving 277,386 shares worth $60.3M. The position accounts for 0.47% of the portfolio, ranked #52.
Zurich Insurance Group first reported a position in ABBV in Q4 2015 and has held it in 29 quarters since. The position peaked at $185M in Q3 2025. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Zurich Insurance Group held 277,386 shares of AbbVie worth $60.3M as of Q1 2026.
- Zurich Insurance Group sold 102,803 AbbVie shares in Q1 2026, an estimated $22.8M.
- AbbVie made up 0.47% of Zurich Insurance Group's portfolio in Q1 2026, its #52 holding.
- Zurich Insurance Group first reported a position in AbbVie in Q4 2015 and has held it in 29 quarters since.
- Zurich Insurance Group's AbbVie position peaked at $185M in Q3 2025.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Zurich Insurance Group's 13F filing for Q1 2026, filed 15 May 2026.